Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
Swiss Cancer Institute
AstraZeneca
University Hospital Southampton NHS Foundation Trust
University of Miami
Ruijin Hospital
University of Birmingham
Swedish Medical Center